| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |